DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $792,627,647 | +5.9% | 3,194,791 | +2.5% | 4.03% | +13.5% |
| Q2 2023 | $748,158,960 | +12.3% | 3,117,329 | +18.0% | 3.55% | -8.1% |
| Q1 2023 | $665,951,682 | -0.3% | 2,642,246 | +5.0% | 3.86% | -11.2% |
| Q4 2022 | $667,728,507 | +13.4% | 2,515,743 | +10.4% | 4.35% | -1.2% |
| Q3 2022 | $588,677,000 | -10.5% | 2,279,130 | -12.1% | 4.40% | -6.5% |
| Q2 2022 | $657,377,000 | -20.2% | 2,593,000 | -7.6% | 4.70% | +3.2% |
| Q1 2022 | $823,319,000 | +19.8% | 2,806,799 | +34.4% | 4.56% | +30.0% |
| Q4 2021 | $687,227,000 | +75.5% | 2,088,773 | +62.4% | 3.51% | +76.9% |
| Q3 2021 | $391,596,000 | +11.9% | 1,286,284 | -1.4% | 1.98% | +8.0% |
| Q2 2021 | $349,918,000 | +19.0% | 1,303,916 | -0.2% | 1.84% | +8.8% |
| Q1 2021 | $294,043,000 | +3.1% | 1,306,394 | +1.7% | 1.69% | -8.9% |
| Q4 2020 | $285,286,000 | -10.9% | 1,284,262 | -13.6% | 1.85% | -16.8% |
| Q3 2020 | $320,219,000 | +13.7% | 1,487,107 | -6.6% | 2.23% | +8.1% |
| Q2 2020 | $281,550,000 | +58.4% | 1,592,208 | +24.0% | 2.06% | +7.5% |
| Q1 2020 | $177,724,000 | -15.9% | 1,284,034 | -6.7% | 1.92% | -3.1% |
| Q4 2019 | $211,275,000 | +6.8% | 1,376,565 | +0.5% | 1.98% | -0.3% |
| Q3 2019 | $197,899,000 | +59.1% | 1,370,207 | +57.4% | 1.99% | +55.4% |
| Q2 2019 | $124,387,000 | – | 870,325 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |